Baird Initiates Coverage On Abbott Laboratories with Outperform Rating, Announces Price Target of $121
Baird analyst David Rescott initiates coverage on Abbott Laboratories (NYSE: ABT ) with a Outperform rating and announces Price Target of $121.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.